XENE vs AROC

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and Archrock Inc (AROC, Company).

XENE is from the Healthcare sector, while AROC is from the Energy sector.

5-Year PerformanceAROC has outperformed XENE, delivering a return of +41.6% compared to +29.9%

XENE vs AROC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	AROC(COMPANY)
Market Cap	$6.54B	$6.53B
Max Drawdown	90.43%	87.04%
Sharpe Ratio	1.44	1.59
5Y Beta	0.92	1.15
Industry	Biotechnology	Oil & Gas Equipment & Services
P/E Ratio	-14.55	23.42
Forward P/E	N/A	20.33
PEG Ratio	-0.36	0.31
Dividend Yield	N/A	2.23%
5Y Dividends CAGR	N/A	8.20%
5Y EPS CAGR	40.27%	36.64%
Debt to Equity	0.00%	156.72%
Free Cash Flow Yield	-4.70%	10.61%
P/S Ratio	727.44	4.45
P/B Ratio	4.89	4.40

Market Cap

Winner

XENE

$6.54B

AROC

$6.53B

Max Drawdown

XENE

90.43%

Winner

AROC

87.04%

Sharpe Ratio

XENE

1.44

Winner

AROC

1.59

5Y Beta

Winner

XENE

0.92

AROC

1.15

Industry

XENE

Biotechnology

AROC

Oil & Gas Equipment & Services

P/E Ratio

Winner

XENE

-14.55

AROC

23.42

Forward P/E

XENE

N/A

AROC

20.33

PEG Ratio

Winner

XENE

-0.36

AROC

0.31

Dividend Yield

XENE

N/A

AROC

2.23%

5Y Dividends CAGR

XENE

N/A

AROC

8.20%

5Y EPS CAGR

Winner

XENE

40.27%

AROC

36.64%

Debt to Equity

Winner

XENE

0.00%

AROC

156.72%

Free Cash Flow Yield

XENE

-4.70%

Winner

AROC

10.61%

P/S Ratio

XENE

727.44

Winner

AROC

4.45

P/B Ratio

XENE

4.89

Winner

AROC

4.40

XENE vs AROC - Historical Returns

Returns include dividend reinvestment.

Period	XENE	AROC
1 month	+28.83%	+3.22%
3 months	+14.63%	+2.56%
6 months	+67.53%	+41.19%
1 year	+111.83%	+64.33%
5 years(CAGR)	+29.95%	+41.63%
10 years(CAGR)	+24.13%	+20.23%
Max(CAGR)	+17.17%	+16.63%

Winner

XENE

+28.83%

AROC

+3.22%

Winner

XENE

+14.63%

AROC

+2.56%

Winner

XENE

+67.53%

AROC

+41.19%

Winner

XENE

+111.83%

AROC

+64.33%

5Y(CAGR)

XENE

+29.95%

Winner

AROC

+41.63%

10Y(CAGR)

Winner

XENE

+24.13%

AROC

+20.23%

Max(CAGR)

Winner

XENE

+17.17%

AROC

+16.63%

XENE vs AROC - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	XENE	AROC
2026	+50.55%	+40.35%
2025	+11.58%	+6.21%
2024	-12.71%	+69.80%
2023	+23.62%	+85.14%
2022	+24.82%	+23.92%
2021	+111.94%	-9.68%
2020	+12.10%	-6.16%
2019	+96.26%	+33.19%
2018	+119.48%	-21.59%
2017	-64.01%	-20.40%
2016	-3.27%	+89.70%
2015	-57.01%	-40.32%
2014	+88.10%	N/A

XENE vs AROC Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for AROC was -84.86%, occurring on Mar 18, 2020. Recovery took 1520 trading sessions.

The current XENE drawdown is -5.61%. The current AROC drawdown is -12.04%.

Rank	XENE	AROC
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-84.86% Feb 15, 2017 - Mar 2, 2023
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-69.30% Nov 4, 2015 - Aug 18, 2016
#3	-34.08% May 9, 2023 - Dec 22, 2023	-30.30% Jan 21, 2025 - Jan 30, 2026
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-23.64% Jul 22, 2024 - Nov 11, 2024
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-20.26% Mar 3, 2023 - Jul 28, 2023
#6	-18.40% Mar 9, 2026 - Jul 7, 2026	-17.55% Oct 10, 2016 - Nov 17, 2016
#7	-17.08% Mar 1, 2023 - May 3, 2023	-16.86% May 5, 2026 - Jun 25, 2026
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-13.23% May 20, 2024 - Jul 11, 2024
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-13.12% Sep 8, 2016 - Sep 28, 2016
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-12.92% Jun 26, 2026 - Jul 6, 2026
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-10.84% Dec 11, 2024 - Jan 13, 2025
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-10.15% Apr 5, 2024 - May 20, 2024
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-9.67% Sep 27, 2023 - Nov 2, 2023
#14	-6.08% Dec 29, 2014 - Jan 7, 2015	-9.25% Dec 19, 2023 - Jan 26, 2024
#15	-5.61% Jul 9, 2026 - Jul 16, 2026	-9.19% Dec 9, 2016 - Jan 4, 2017